Achillion Pharmaceuticals upgraded By: MarketMinute.com Stock News May 18, 2017 at 18:48 PM EDT Leerink Partners upgraded Achillion Pharmaceuticals Inc. (Nasdaq: ACHN) from a Market Perform rating to an Outperform rating lifting the stock price 63 cents to close at $4.41. Related Stocks: Achison Inc